Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Recruiting

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Sponsor:

LumiraDx UK Limited

Code:

NCT04288921

Conditions

Influenza, Human

Respiratory Syncytial Virus Infections

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Swab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by LumiraDx UK Limited on 2023-03-13.